$1.72
0.148.86%
At Close: -
$1.67
-0.05-2.84%
After Hours: 4:43 PM EDT
15 minutes delayed
Coherus BioSciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Coherus BioSciences using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CHRS | Coherus BioSciences | -$0.38 | -$0.16 | — | — | $58.72M | $64.16M | — | — | 08/09/2024 | Get Alert |
CHRS | Coherus BioSciences | -$0.75 | -$0.24 | -$0.32 | -33.33% | $32.44M | $80.25M | $77.06M | -3.97% | 05/09/2024 | Get Alert |
CHRS | Coherus BioSciences | -$0.60 | -$0.12 | -$0.62 | -416.67% | $45.35M | $96.40M | $91.52M | -5.06% | 03/13/2024 | Get Alert |
CHRS | Coherus BioSciences | -$0.96 | -$0.31 | -$0.27 | 12.90% | $45.42M | $83.56M | $74.57M | -10.76% | 11/06/2023 | Get Alert |
CHRS | Coherus BioSciences | -$0.47 | -$0.52 | -$0.38 | 26.92% | $60.15M | $50.83M | $58.72M | 15.51% | 08/02/2023 | Get Alert |
CHRS | Coherus BioSciences | -$1.00 | -$0.57 | -$0.75 | -31.58% | $60.12M | $47.44M | $32.44M | -31.63% | 05/08/2023 | Get Alert |
CHRS | Coherus BioSciences | -$0.46 | -$0.84 | -$0.60 | 28.57% | $73.37M | $51.22M | $45.35M | -11.46% | 03/06/2023 | Get Alert |
CHRS | Coherus BioSciences | -$0.34 | -$0.57 | -$0.96 | -68.42% | $82.50M | $56.91M | $45.42M | -20.18% | 11/08/2022 | Get Alert |
CHRS | Coherus BioSciences | -$0.36 | -$0.65 | -$0.47 | 27.69% | $87.64M | $61.31M | $60.15M | -1.89% | 08/04/2022 | Get Alert |
CHRS | Coherus BioSciences | $0.01 | -$0.48 | -$1.00 | -108.33% | $83.03M | $68.95M | $60.12M | -12.81% | 05/05/2022 | Get Alert |
CHRS | Coherus BioSciences | $0.23 | -$0.51 | -$0.46 | 9.80% | $110.42M | $85.81M | $73.37M | -14.50% | 02/17/2022 | Get Alert |
CHRS | Coherus BioSciences | $0.47 | -$0.22 | -$0.34 | -54.55% | $113.55M | $91.31M | $82.50M | -9.65% | 11/08/2021 | Get Alert |
CHRS | Coherus BioSciences | $0.81 | -$0.17 | -$0.36 | -111.76% | $135.67M | $89.81M | $87.64M | -2.41% | 08/05/2021 | Get Alert |
CHRS | Coherus BioSciences | $0.48 | $0.06 | $0.01 | -83.33% | $116.18M | $96.00M | $83.03M | -13.51% | 05/06/2021 | Get Alert |
CHRS | Coherus BioSciences | $0.53 | $0.23 | $0.23 | 0.00% | $123.86M | $115.12M | $110.42M | -4.08% | 02/24/2021 | Get Alert |
CHRS | Coherus BioSciences | $0.63 | $0.41 | $0.47 | 14.63% | $111.68M | $122.88M | $113.55M | -7.59% | 11/05/2020 | Get Alert |
CHRS | Coherus BioSciences | $0.32 | $0.33 | $0.81 | 145.45% | $83.43M | $104.95M | $135.67M | 29.27% | 08/06/2020 | Get Alert |
CHRS | Coherus BioSciences | -$0.29 | $0.56 | $0.48 | -14.29% | $37.10M | $119.52M | $116.18M | -2.79% | 05/07/2020 | Get Alert |
CHRS | Coherus BioSciences | -$0.92 | $0.72 | $0.53 | -26.39% | $0.00 | $123.01M | $123.86M | 0.69% | 02/27/2020 | Get Alert |
CHRS | Coherus BioSciences | -$0.87 | $0.51 | $0.63 | 23.53% | $0.00 | $101.37M | $111.68M | 10.17% | 11/06/2019 | Get Alert |
CHRS | Coherus BioSciences | -$0.68 | $0.08 | $0.32 | 300.00% | $0.00 | $75.49M | $83.43M | 10.52% | 08/01/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $-0.32 | $-0.24 | -33.3 % |
Dec 2023 | 2024-03-13 | $-0.62 | $-0.12 | -416.7 % |
Sep 2023 | 2023-11-06 | $-0.27 | $-0.31 | 12.9 % |
Jun 2023 | 2023-08-02 | $-0.38 | $-0.52 | 26.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $77.06M | $80.25M | -3.97 % |
Dec 2023 | 2024-03-13 | $91.52M | $96.40M | -5.06 % |
Sep 2023 | 2023-11-06 | $74.57M | $83.56M | -10.8 % |
Jun 2023 | 2023-08-02 | $58.72M | $50.83M | 15.5 % |
Coherus BioSciences (CHRS) is scheduled to report earnings on August 9, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
The Actual EPS was $-0.32, which missed the estimate of $-0.24.
The Actual Revenue was $77.1M, which missed the estimate of $80.3M.
Browse earnings estimates, EPS, and revenue on all stocks.